Showing 61 - 70 of 2225 results

Showing Results for: “type diabetes”

Oral Semaglutide Reduces Occurrence of Major Cardiac Events in People with Type 2 Diabetes With High Cardiovascular Risk

Results of the PIONEER 6 trial indicate oral semaglutide is safe for patients with type 2 diabetes (T2D) at high cardiovascular (CV) risk, according to results announced at the symposium titled “Oral Semaglutide—The PIONEER Program Trials” today at the American Diabetes Association’s® (ADA) 79th Scientific Sessions® at the Moscone Convention Center in San Francisco. Oral semaglutide reduced cardiovascular death and all-cause mortality by nearly 50 percent, based on median follow up of 15.9 months. PIONEER 6 was conducted across 21 countries and included 3,183 participants who were randomized

Sharing My Story: Danielle

Danielle has been living with type 2 diabetes for seven years. She’s written two books to empower and educate others living with diabetes. This is her story: Hello, my name is Danielle, and I'm a type 2 diabetic. I was first diagnosed back in 2013, and I instantly went into denial because I could not believe I was a diabetic. I instantly stereotyped what and who I should be as someone with diabetes. I was in denial for a very long time, but when my first symptom showed up, I took control of my life and became a fighting machine against this disease. I became an author with my first book, Let

Delayed Onset of Type 2 Diabetes by Six Years or More Significantly Reduces Risk of Cardiovascular Disease and Microvascular Disease

People with impaired glucose tolerance (IGT) may significantly lower their risk of cardiovascular disease (CVD) and microvascular disease by delaying the onset of type 2 diabetes (T2D) by six years or more, or by returning to a normal level of glucose tolerance altogether, according to the study, “Early Progression to Diabetes or Regression to Normal Glucose Tolerance Among People with Impaired Glucose Tolerance Affects Long-Term Outcomes: Thirty-Year Follow-Up of Da Qing Diabetes Prevention Study,” presented today at the American Diabetes Association’s® (ADA’s) 79th Scientific Sessions® at

Sharing My Story: Noelle & Ella

Ella's diagnosis came as a shock to Noelle, her mother. Now, Noelle is committed to educating others about the warning signs of type 1 diabetes. This is Noelle's story: Ella was brought to the doctor when she was 22 months old, when I was concerned about her weight loss and constant peeing through diapers. We were told it was a urinary tract infection (UTI) and sent on our way. Luckily, mama's intuition was a bit stronger and I pushed for a urine test. Just 24 hours later, we were in the pediatric intensive care unit in diabetic ketoacidosis (DKA), and left with a new type 1 diabetes diagnosis

Sharing My Story: Jeris

Jeris, from Mechanicsburg, Ohio, was diagnosed with type 1 diabetes (T1D) when she was just under two years old—but she hasn't let it hold her back. This is her story: I was diagnosed with type 1 diabetes when I was 23 months old. Throughout my life I've never let diabetes stop me or slow me down. Diabetes has taught me so much and it's allowed me to help a few newly diagnosed kids by sharing my story with their parents. It makes me so happy that I can use my experiences to help other people. Diabetes has shown me the kindness of others when they have helped me when I'm low. It's made me so

Sharing My Story: Nikki

Nikki lives with type 2 diabetes—and thrives, despite her diagnosis and her experience with several diabetes-related complications. My name is Nikki and I am a type 2 diabetic of seven years. For the last two years, I've spent my New Years’ Eves in the ICU battling acute pancreatitis, sepsis, and ketoacidosis. I treat every day as a blessing and a gift, as each hospitalization was worse than the last. As such, I've vowed to train for a marathon to run in honor of the American Diabetes Association and have also raised $1,000 in donations. Additionally, I am an avid Disneyland 'resident.'

Insulin Basics

Learn about the different types of insulin, their characteristics, and strengths. Find the right insulin for your needs and manage your diabetes effectively.

An inspiration: Meet Milford - T1D for 70 Years

Type 1 diabetes? There are many ways to describe it, but at its core, it is a lifelong autoimmune disease that changes the way you live from the moment of diagnosis. However, what many people don’t know is that living with type 1 diabetes is often a test of strength and endurance, something no one understood better than Milford Driskill. Born February 19, 1940, Milford was an active kid growing up in Kansas. In 1952, at the age of 12, he was diagnosed with type 1 diabetes which back then, was known as juvenile diabetes. Insulin had only been discovered 30 years prior and Milford was told if he

New Study Shows Open-Source Automated Insulin Delivery is a Safe and Effective Treatment Option for People with Type 1 Diabetes

First-of-Its-Kind Study Compares Open-Source Automated Insulin Delivery to Sensor-Augmented Pump Therapy Results from the CREATE Trial demonstrated open-source automated insulin delivery (AID) systems are a safe and effective therapy for people with type 1 diabetes. Findings from the randomized controlled trial (RCT) comparing open-source AID to sensor-augmented pump therapy (SAPT) were presented today at the 82nd Scientific Sessions of the American Diabetes Association ® (ADA). Open-source AID systems were developed to reduce the burden of living with diabetes by combining an insulin pump

New Study Shows Hospitalization Rates for New Onset Pediatric Type 2 Diabetes Doubled During COVID-19 Pandemic

Initial data indicate that children presented with higher acuity compared to the previous year New data show that the incidence and acuity of type 2 diabetes in children increased significantly during the peak of the COVID-19 pandemic, with more pediatric patients hospitalized from March to December 2020 compared to the same time period in 2019. Findings from the retrospective chart review were presented as a late-breaking poster session at the virtual 81st Scientific Sessions of the American Diabetes Association ® (ADA). Stay-at-home orders due to the COVID-19 pandemic exacerbated risk